Retzius‐sparing RALP vs standard RALP
Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).
1 finding from 1 review
- Retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized… 2020 · Cochrane Headline outcomes onlyHR 0.45 [0.13, 1.6]2 studies · 218 participantsVery low